Search results for " BURDEN"

showing 10 items of 325 documents

Reducing the burden of Herpes Zoster in Italy.

2015

Herpes Zoster (HZ) is a viral disease with painful neuro-dermatologic manifestations. Incidence increases with age. In Italy, the estimated incidence is 6.3 cases/1000 person/year; hospital admissions are less than 2%, 69% in patients aged over 65 years. The most frequent complication of HZ is Post-Herpetic Neuralgia (PHN) characterized by metameric pain, allodynia, and hyperalgesia. In Italy 20.6% and 9.2% of HZ patients experience PHN after 3 and 6 months, respectively. Available antiviral and analgesic treatments are relatively unsatisfactory in reducing pain and length of the disease. Prevention has recently become possible with the live attenuated vaccine Oka/Merck. Clinical studies sh…

medicine.medical_specialtyPediatricsHerpes Zoster epidemiology burden prevention immunizationSettore MED/17 - Malattie InfettiveCost-Benefit AnalysisImmunologyNeuralgia PostherpeticDiseaseSettore MED/42 - Igiene Generale E ApplicataimmunizationHerpes ZosterHerpes Zoster; epidemiology; burden; prevention; immunizationburdenChickenpox VaccinepreventionEpidemiologymedicineHumansImmunology and AllergyChickenpox VaccinePharmacologyHerpes Zoster; burden; epidemiology; immunization; preventionbusiness.industryIncidenceIncidence (epidemiology)medicine.diseaseSurgeryVaccinationAllodyniaItalyNeuralgiaepidemiologyViral diseasemedicine.symptombusinessResearch Paper
researchProduct

I06 Dysphagia In Huntington`s Disease: A Multicenter Study

2014

Background Dysphagia is a common complication of neurogenerative disorders, and a leading cause of death due to aspiration pneumonia. Little is known about the frequency and the characteristics of dysphagia in HD. Well-balanced strategies for treatment and prevention of dysphagia in HD are lacking. Objetives To determine the prevalence of dysphagia in HD. Methods National, multicenter, observational, cross-sectional Study (Spanish EHDN). Dysphagia was assessed using the questionnaire EAT-10 (eating assessment tool), caregiver burden using the SumaCare, functional capacity using the TFC score, disease severity using the Unified HD Rating Scale (UHDRS), psyquiatric status (PBA-s), nutritional…

medicine.medical_specialtyPediatricsbusiness.industryCaregiver burdenAspiration pneumoniamedicine.diseaseDysphagiaPsychiatry and Mental healthHuntington's diseaseQuality of lifeotorhinolaryngologic diseasesNursing Interventions ClassificationPhysical therapyMedicineSurgeryNeurology (clinical)medicine.symptombusinessBody mass indexCause of deathJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Thrombosis

2014

Background— Thrombosis is the common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused 1 in 4 deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. Objective— To review the literature on the global burden of disease caused by VTE. Approach and Results— We performed a systematic review of the literature on the global disease burden because of VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded…

medicine.medical_specialtyPopulation ageingPopulationMyocardial IschemiaDisease030204 cardiovascular system & hematologyGlobal HealthCohort Studies03 medical and health sciencesLife Expectancy0302 clinical medicineCost of IllnessCause of DeathEnvironmental healthGlobal healthPrevalenceHumansMedicinecardiovascular diseases030212 general & internal medicineIntensive care medicineeducationStrokeDisease burdenCause of deathVenous Thrombosiseducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Racial GroupsAge FactorsThrombosisVenous ThromboembolismHematologymedicine.diseaseThrombosis3. Good healthStrokePneumoniaVenous thrombosisSocial ClassQuality-Adjusted Life YearsMedical emergencyPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

REVIEW OF RETROSPECTIVE DOSIMETRY TECHNIQUES FOR EXTERNAL IONISING RADIATION EXPOSURES

2011

The current focus on networking and mutual assistance in the management of radiation accidents or incidents has demonstrated the importance of a joined-up approach in physical and biological dosimetry. To this end, the European Radiation Dosimetry Working Group 10 on 'Retrospective Dosimetry' has been set up by individuals from a wide range of disciplines across Europe. Here, established and emerging dosimetry methods are reviewed, which can be used immediately and retrospectively following external ionising radiation exposure. Endpoints and assays include dicentrics, translocations, premature chromosome condensation, micronuclei, somatic mutations, gene expression, electron paramagnetic re…

medicine.medical_specialtyProtein biomarkersOptically stimulated luminescence[SDV]Life Sciences [q-bio]Radiation DosageRisk AssessmentRetrospective dosimetry030218 nuclear medicine & medical imagingIonizing radiation03 medical and health sciences0302 clinical medicineRadiation MonitoringRadiation IonizingHumansMedicineDosimetryRadiology Nuclear Medicine and imagingMedical physicsRadiometryRetrospective StudiesRadiationRadiological and Ultrasound Technologybusiness.industryPublic Health Environmental and Occupational HealthGeneral MedicineIntegrated approach030220 oncology & carcinogenesisBody BurdenRadiation monitoringbusinessIonising radiation exposureRadiation Accidents
researchProduct

Radiation exposure in CT-guided interventions.

2013

To investigate radiation exposure in computed tomography (CT)-guided interventions, to establish reference levels for exposure, and to discuss strategies for dose reduction.We analyzed 1576 consecutive CT-guided procedures in 1284 patients performed over 4.5 years, including drainage placements; biopsies of different organs; radiofrequency and microwave ablations (RFA/MWA) of liver, bone, and lung tumors; pain blockages, and vertebroplasties. Data were analyzed with respect to scanner settings, overall radiation doses, and individual doses of planning CT series, CT intervention, and control CT series.Eighty-five percent of the total radiation dose was applied during the pre- and post-interv…

medicine.medical_specialtyPsychological interventionComputed tomographyRadiation DosageRadiography InterventionalGermanymedicineHumansRadiology Nuclear Medicine and imagingRadiometrymedicine.diagnostic_testbusiness.industryRadiation doseInterventional radiologyGeneral MedicineEnvironmental ExposureRadiation exposureSurgery Computer-AssistedBody BurdenDose reductionRadiologyRadiation protectionNuclear medicinebusinessImage-Guided BiopsyTomography X-Ray ComputedEnvironmental MonitoringEuropean journal of radiology
researchProduct

Uncertainty on radiation doses estimated by biological and retrospective physical methods

2018

International audience; Biological and physical retrospective dosimetry are recognised as key techniques to provide individual estimates of dose following unplanned exposures to ionising radiation. Whilst there has been a relatively large amount of recent development in the biological and physical procedures, development of statistical analysis techniques has failed to keep pace. The aim of this paper is to review the current state of the art in uncertainty analysis techniques across the 'EURADOS Working Group 10- Retrospective dosimetry' members, to give concrete examples of implementation of the techniques recommended in the international standards, and to further promote the use of Monte…

medicine.medical_specialtyRadiology Nuclear Medicine and Imaging[SDV]Life Sciences [q-bio]Public Health and Health CareRadiation DosageRisk Assessment030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineRadiation MonitoringRadiation IonizingmedicineDosimetryHumansStatistical analysisMedical physicsRadiometryUncertainty analysisMathematicsRadiationRadiological and Ultrasound TechnologyPhysicsUncertaintyPublic Health Environmental and Occupational HealthGeneral Medicineretrospective dosimetry biodosimetry physical dosimetry uncertainityEuropeChemistryWork (electrical)030220 oncology & carcinogenesisRadiation monitoringBody BurdenRisk assessmentWhole bodyMathematicsHuman
researchProduct

Acute gastroenteritis outbreaks in Catalonia, Spain: norovirus versus Salmonella.

2008

Objective. To describe the epidemiology of norovirus (NV) and Salmonella gastroenteritis outbreaks in Catalonia between 15 October 2004 and 30 October 2005. Material and methods. Epidemiological data were obtained from outbreak reports. The aetiologic agent was investigated by culture for enteric bacteria, enzyme immunoanalyses, reverse transcription polymerase chain reaction (RT-PCR) and molecular epidemiology genotyping for NV. The x 2 test was used to compare proportions. Incidence rates and their confidence intervals (CI) were calculated assuming a Poisson distribution. Results. A total of 225 acute gastroenteritis (AG) outbreaks were reported, with 3436 persons affected and 115 hospita…

medicine.medical_specialtySalmonellaAttack ratemedicine.disease_causeDisease OutbreaksFoodborne DiseasesInternal medicineEpidemiologymedicineHumansDisease burdenCaliciviridae Infectionsbusiness.industryIncidence (epidemiology)IncidenceNorovirusGastroenterologyOutbreakOdds ratioVirologyGastroenteritisSpainAcute DiseaseNorovirusSalmonella Food PoisoningbusinessScandinavian journal of gastroenterology
researchProduct

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retr…

2021

Abstract Background Homozygous familial hypercholesterolemia (HoFH) is a rare life-threatening condition that represents a therapeutic challenge. The vast majority of HoFH patients fail to achieve LDL-C targets when treated with the standard protocol, which associates maximally tolerated dose of lipid-lowering medications with lipoprotein apheresis (LA). Lomitapide is an emerging therapy in HoFH, but its place in the treatment algorithm is disputed because a comparison of its long-term efficacy versus LA in reducing LDL-C burden is not available. We assessed changes in long-term LDL-C burden and goals achievement in two independent HoFH patients’ cohorts, one treated with lomitapide in Ita…

medicine.medical_specialtySettore MED/09 - Medicina Interna[SDV]Life Sciences [q-bio]LipoproteinsGenetic diseaseTherapeuticsFamilial hypercholesterolemiaDiseaseLipoprotein apheresiLDLHyperlipoproteinemia Type IIchemistry.chemical_compoundLipoprotein apheresisRetrospective surveyInternal medicineCholesterol burden; Genetic disease; Homozygous hypercholesterolemia; LDL; Lipoprotein apheresis; Lomitapide; Therapeutics; Benzimidazoles; Homozygote; Humans; Lipoproteins; Retrospective Studies; Anticholesteremic Agents; Blood Component Removal; Hyperlipoproteinemia Type IImedicineHumansPharmacology (medical)Genetics (clinical)Retrospective Studiesmedicine.diagnostic_testbusiness.industryResearchAnticholesteremic AgentsHomozygous hypercholesterolemiaHomozygoteRGeneral Medicinemedicine.diseaseLomitapideLomitapidecholesterol burden; genetic disease; homozygous hypercholesterolemia; LDL; lipoprotein apheresis; lomitapide; therapeuticsCholesterol burdenchemistryCohortBlood Component RemovalMedicineTherapeutics.BenzimidazolesLipid profilebusinessLipoprotein apheresisCross nationalOrphanet Journal of Rare Diseases
researchProduct

The burden of disease in Spain: Results from the Global Burden of Disease 2016

2018

Abstract Background and objectives The global burden of disease (GBD) project measures the health of populations worldwide on an annual basis, and results are available by country. We used the estimates of the GBD to summarise the state of health in Spain in 2016 and report trends in mortality and morbidity from 1990 to 2016. Material and methods GBD 2016 estimated disease burden due to 333 diseases and injuries, and 84 risk factors. The GBD list of causes is hierarchical and includes 3 top level categories, namely: (1) communicable, maternal, neonatal, and nutritional diseases; (2) non-communicable diseases (NCDs), and (3) injuries. Mortality and disability-adjusted life-years (DALYs), ris…

medicine.medical_specialtybusiness.industryDisease030204 cardiovascular system & hematologymedicine.diseaseObesity03 medical and health sciences0302 clinical medicineYears of potential life lostEnvironmental healthEpidemiologymedicineDementia030212 general & internal medicineRisk factorbusinessDisease burdenCause of deathMedicina Clínica (English Edition)
researchProduct

2015

Quality of life (QoL) is increasingly recognized as central to the broad construct of recovery in patients with substance use disorders (SUD). However, few longitudinal studies have evaluated changes in QoL after SUD treatment and included patients with SUD that were compulsorily hospitalized. This study aimed to describe QoL among in-patients admitted either voluntarily or compulsorily to hospitalization and to examine patterns and predictors of QoL at admission and at 6 months post treatment. This prospective study followed 202 hospitalized patients with SUD that were admitted voluntarily (N=137) or compulsorily (N=65). A generic QoL questionnaire (QoL-5) was used to assess QoL domains. R…

medicine.medical_specialtybusiness.industryPublic Health Environmental and Occupational HealthSymptom burdenGeneral Medicinemedicine.diseasehumanitiesConfidence intervalSubstance abuseQuality of lifePhysical therapyMedicineIn patientSubstance usePost treatmentbusinessProspective cohort studyHealth and Quality of Life Outcomes
researchProduct